comparemela.com

Latest Breaking News On - Thi dao - Page 1 : comparemela.com

Imexpharm welcomes shareholders, analysts and potential investors at AGM

Imexpharm Corporation (Imexpharm), a pioneering leader in Vietnam’s pharmaceutical industry, held its AGM at the Hilton Saigon Hotel on April 26.

Vietnam
Republic-of
Vietnamese
Chaerhan-chun
National-assembly
Imexpharm-corporation
European-union-marketing-authorisations-mas
Thi-dao
Union-marketing-authorisations
Imexpharm
Agm-2024

Imexpharm opens new representative office in Ho Chi Minh City

Imexpharm has opened a new office to grasp fresh opportunities for growth after a period of in-depth investment in modern production technologies.

Vietnam
Republic-of
Ho-chi-minh-city
H-chíinh
Mekong-delta
Vietnam-general
Mongolia
Vietnamese
Flemington-tower
Dai-hanh
Thi-dao

Domestic pharmaceutical products anticipate 2024 boost

Despite a challenging 2023, the pharmaceutical industry remains healthy thanks to the breakthroughs of leading pharmaceutical companies.

South-korea
Thailand
Mongolia
Vietnam
Republic-of
Barcelona
Comunidad-autonoma-de-cataluna
Spain
Cambodia
South-korean
Vietnamese
Pymepharco-pme-stada

Imexpharm aims for high-quality products at affordable prices for patients

With 11 production lines that all met EU-GMP standards, Imexpharm Pharmaceutical Joint Stock Company (Imexpharm) aims to make high-quality products at reasonable prices for patients.

Binh-duong
Qu-ng-nam
Vietnam
Republic-of
Sk-group-korea
Drug-administration-of-vietnam
Vietnam-institute-of-directors
Thi-dao
General-director
Drug-administration
Vietnam-institute

Imexpharm raises its status with EU-GMP-standard factories

With the largest pharmaceutical production lines that meet European standards (EU-GMP) in Vietnam, Imexpharm has great potential to become an industry leader.

Binh-duong
Qu-ng-nam
Vietnam
Republic-of
Japan
Vietnamese
Sk-group-south-korea
Ministry-of-health
Drug-administration-of-vietnam
Imexpharm-corporation
Drug-administration

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.